Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine

News   May 09, 2013

 
Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine
 
 
 

RELATED ARTICLES

Metabolomic Profiling Identifies Taurine as New MS Therapeutic

News

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.

READ MORE

Data Storage at the Single Molecule Level

News

A research team from Kiel University has now not only managed to successfully place a new class of spin-crossover molecules onto a surface, but they have also used interactions which were previously regarded as obstructive to improve the molecule's storage capacity.

READ MORE

How Ribosomes Shape the Proteome

News

Cells are crowded with macromolecules, which limits the diffusion of proteins, especially in prokaryotic cells without active transport in the cytoplasm. While investigating the relationship between crowding, ionic strength and protein diffusion, biochemists made a fascinating discovery: positively charged proteins stick to the surface of ribosome complexes. This explains why most water-soluble proteins carry an overall negative charge.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research Informatics & Automation Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE